News Focus
News Focus
icon url

DewDiligence

04/06/20 11:56 PM

#230609 RE: miljenko #230608

VIR—The answers to some of those questions will likely remain trade secrets for a little while.
icon url

DewDiligence

06/03/20 6:40 PM

#232883 RE: miljenko #230608

VIR -10%—perhaps some investors were hoping VIR/GSK would be a finalist in Operation Warp Speed (#msg-156027500).

Such an outcome was never in the cards because the VIR/GSK collaboration is mostly about COVID-19 antibodies rather than vaccines (https://www.globenewswire.com/news-release/2020/04/06/2012095/0/en/GSK-and-Vir-Biotechnology-enter-collaboration-to-find-coronavirus-solutions.html ).
icon url

DewDiligence

02/17/21 10:32 AM

#237143 RE: miljenko #230608

Are you still long VIR?